neomycin sulphate upjohn feed additive powder
zoetis australia pty ltd - neomycin as the sulfate - oral powder, pre-mix - neomycin as the sulfate antibiotic active 1000.0 g/kg - nutrition & metabolism - cattle | pigs | poultry | beef | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bull | bullock | calf - bacterial enteritis | escherichia coli (e. coli) | proteus spp. | pseudomonas spp. | salmonella | including b-lactamase producin | post-weaning bacterial enterit | salmonellosis
tp-neocin 500 wsp neomycin sulphate 500mgg powder
thye pharma sdn. bhd - neomycin sulphate; neomycin sulphate -
aah neomycin sulphate feed additive powder
allied animal health pty ltd - neomycin base (as the sulfate) - oral powder, pre-mix - neomycin base (as the sulfate) antibiotic active 1000.0 g/kg - antibiotic & related - cattle | pigs | poultry | beef | boar | bos indicus | bos taurus | bovine | breeders | broiler | buffalo | bull | bullock | calf - scours | selenium responsive scours
neomycin penicillin 100/200 aqueous suspension for intramuscular injection
intervet australia pty limited - neomycin base (as the sulfate); procaine penicillin - parenteral liquid/solution/suspension - neomycin base (as the sulfate) antibiotic active 100.0 mg/ml; procaine penicillin antibiotic-penicillin active 200.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - actinobacillus pleuropneumoniae (haemoph | actinomyces spp. | antibiotic - anti-infective | clostridia | erysipelothrix spp. | escherichia coli (e. coli) | infections of the urinary tracts | klebsiella spp. | leptospirosis | mastitis | metritis | pasteurella multocida | pasteurella spp. | salmonella | staphylococcus aureus | streptococci | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | escherichia coli | feed efficiency | fowl cholera | fungal infections | girth galls | group d streptococcus | including b-lactamase producin | infections | inflammed pads | itching | keratolytic | klebsiella spp. | l. hardjo | l. interrogans | l. pomona | l. tarassovi | lacerations | mastitis | mycoplasmas | odours | open wou
ccd neomycin (neomycin sulphate water soluble powder)
ccd animal health pty ltd - neomycin sulfate - oral powder, pre-mix - neomycin sulfate antibiotic active 600.0 mg/g - nutrition & metabolism - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - enteritis
neomycin sulphate cream usp 0.5%ww topical external creams
good day pharmacy limited - neomycin sulphate cream usp - topical external creams - 0.5%ww
neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone- neomycin sulfate, polymyxin b sulfate, bacitracin zinc a
mwi - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin 3.5 mg in 1 g - neomycin and polymyxin b sulfates, bacitracin zinc, and hydrocortisone ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology). the particular anti-infective drugs in this product
neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ointment
physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 g - neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ophthalmic ointment is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infect
neomycin, polymyxin b sulfates and hydrocortisone suspension
physicians total care, inc. - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 ml - neomycin and polymyxin b sulfates and hydrocortisone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infective drugs in this produ
neomycin and polymyxin b sulfates and hydrocortisone- neomycin sulfate, polymyxin b sulfate and hydrocortisone suspension
stat rx usa llc - neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - neomycin sulfate 3.5 mg in 1 ml - neomycin and polymyxin b sulfates and hydrocortisone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye (see clinical pharmacology: microbiology ). the particular anti-infective drugs in this produ